Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Amy S PallerAndreas PinterLara Wine LeeRoland AschoffJacek ZdybskiChristina SchnoppAmy PraestgaardAshish BansalBrad ShumelRandy PrescillaMike BastianPublished in: Advances in therapy (2024)
The trial was registered with ClinicalTrials.gov with ID number NCT03346434, part B.